Cellular functions of the protein kinase ATM and their relevance to human disease - Nature Reviews Molecular Cell Biology
- ️Paull, Tanya T.
- ️Tue Aug 24 2021
Rothblum-Oviatt, C. et al. Ataxia telangiectasia: a review. Orphanet J. Rare Dis. 11, 159 (2016).
Shiloh, Y. & Ziv, Y. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat. Rev. Mol. Cell Biol. 14, 197–210 (2013).
Concannon, P. & Gatti, R. A. Diversity of ATM gene mutations detected in patients with ataxia-telangiectasia. Hum. Mutat. 10, 100–107 (1997).
Lovejoy, C. A. & Cortez, D. Common mechanisms of PIKK regulation. DNA Repair. 8, 1004–1008 (2009).
Paull, T. T. Mechanisms of ATM activation. Annu. Rev. Biochem. 84, 711–738 (2015).
Jackson, S. P. & Bartek, J. The DNA-damage response in human biology and disease. Nature 461, 1071–1078 (2009).
Matsuoka, S. et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316, 1160–1166 (2007).
Bensimon, A. et al. ATM-dependent and -independent dynamics of the nuclear phosphoproteome after DNA damage. Sci. Signal. 3, rs3 (2010).
Schlam-Babayov, S. et al. Phosphoproteomics reveals novel modes of function and inter-relationships among PIKKs in response to genotoxic stress. EMBO J. 40, e104400 (2021).
Lavin, M. F. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat. Rev. Mol. Cell Biol. 9, 759–769 (2008).
Zhang, Y. et al. Mitochondrial redox sensing by the kinase ATM maintains cellular antioxidant capacity. Sci. Signal. 11, eaaq0702 (2018).
Lee, J.-H. et al. ATM directs DNA damage responses and proteostasis via genetically separable pathways. Sci. Signal. 11, eaan5598 (2018).
Guo, Z., Kozlov, S., Lavin, M. F., Person, M. D. & Paull, T. T. ATM activation by oxidative stress. Science 330, 517–521 (2010).
Corcoles-Saez, I. et al. Essential function of Mec1, the budding yeast ATM/ATR checkpoint-response kinase, in protein homeostasis. Dev. Cell 46, 495–503.e2 (2018).
Cosentino, C., Grieco, D. & Costanzo, V. ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair. EMBO J. 30, 546–555 (2011).
Sharma, N. K. et al. Intrinsic mitochondrial DNA repair defects in ataxia telangiectasia. DNA Repair. 13, 22–31 (2014).
D’Souza, A. D., Parish, I. A., Krause, D. S., Kaech, S. M. & Shadel, G. S. Reducing mitochondrial ROS improves disease-related pathology in a mouse model of ataxia-telangiectasia. Mol. Ther. 21, 42–48 (2013).
Tresini, M. et al. The core spliceosome as target and effector of non-canonical ATM signalling. Nature 523, 53–58 (2015).
Katzenberger, R. J., Marengo, M. S. & Wassarman, D. A. ATM and ATR pathways signal alternative splicing of Drosophila TAF1 pre-mRNA in response to DNA damage. Mol. Cell Biol. 26, 9256–9267 (2006).
Sarkar, A. et al. Ataxia telangiectasia mutated interacts with Parkin and induces mitophagy independent of kinase activity. Evidence from mantle cell lymphoma. Haematologica 106, 495–512 (2021).
Yates, L. A. et al. Cryo-EM structure of nucleotide-bound Tel1ATM unravels the molecular basis of inhibition and structural rationale for disease-associated mutations. Structure 28, 96–104.e3 (2020).
Baretic´, D. et al. Structures of closed and open conformations of dimeric human ATM. Sci. Adv. 3, e1700933 (2017).
Jansma, M. et al. Near-complete structure and model of Tel1ATM from Chaetomium thermophilum reveals a robust autoinhibited ATP state. Structure 28, 83–95.e5 (2020).
Wang, X. et al. Structure of the intact ATM/Tel1 kinase. Nat. Commun. 7, 11655 (2016).
Lau, W. C. Y. et al. Structure of the human dimeric ATM kinase. Cell Cycle 15, 1117–1124 (2016).
Lee, J. H. & Paull, T. T. ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science 308, 551–554 (2005).
Uziel, T. et al. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 22, 5612–5621 (2003).
Zhou, Y. et al. Regulation of the DNA damage response by DNA-PKcs inhibitory phosphorylation of ATM. Mol. Cell 65, 91–104 (2017).
Sun, Y., Jiang, X., Chen, S., Fernandes, N. & Price, B. D. A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Proc. Natl Acad. Sci. USA 102, 13182–13187 (2005).
Sun, Y., Xu, Y., Roy, K. & Price, B. D. DNA damage-induced acetylation of lysine 3016 of ATM activates ATM kinase activity. Mol. Cell Biol. 27, 8502–8509 (2007).
Bakkenist, C. J. & Kastan, M. B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421, 499–506 (2003).
Kozlov, S. V. et al. Autophosphorylation and ATM activation: additional sites add to the complexity. J. Biol. Chem. 286, 9107–9119 (2010).
Kozlov, S. V. et al. Involvement of novel autophosphorylation sites in ATM activation. EMBO J. 25, 3504–3514 (2006).
Khoronenkova, S. V. Mechanisms of non-canonical activation of ataxia telangiectasia mutated. Biochem. Mosc. 81, 1669–1675 (2016).
Khoronenkova, S. V. & Dianov, G. L. ATM prevents DSB formation by coordinating SSB repair and cell cycle progression. Proc. Natl Acad. Sci. USA 112, 3997–4002 (2015).
Lin, C. P., Ban, Y., Lyu, Y. L. & Liu, L. F. Proteasome-dependent processing of topoisomerase I-DNA adducts into DNA double strand breaks at arrested replication forks. J. Biol. Chem. 284, 28084–28092 (2009).
Sordet, O. et al. Ataxia telangiectasia mutated activation by transcription- and topoisomerase I-induced DNA double-strand breaks. EMBO Rep. 10, 887–893 (2009).
Sordet, O., Nakamura, A. J., Redon, C. E. & Pommier, Y. DNA double-strand breaks and ATM activation by transcription-blocking DNA lesions. Cell Cycle 9, 274–278 (2010).
Cristini, A. et al. DNA-PK triggers histone ubiquitination and signaling in response to DNA double-strand breaks produced during the repair of transcription-blocking topoisomerase I lesions. Nucleic Acids Res. 44, 1161–1178 (2016).
Yang, C. et al. Aurora-B mediated ATM serine 1403 phosphorylation is required for mitotic ATM activation and the spindle checkpoint. Mol. Cell 44, 597–608 (2011).
Yeo, A. J. et al. Impaired endoplasmic reticulum-mitochondrial signaling in ataxia-telangiectasia. iScience 24, 101972 (2021).
Chow, H.-M. et al. ATM is activated by ATP depletion and modulates mitochondrial function through NRF1. J. Cell Biol. 218, 909–928 (2019).
Xin, J. et al. Structural basis of allosteric regulation of Tel1/ATM kinase. Cell Res. 29, 655–665 (2019).
Yang, H. et al. Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40. Nature 552, 368–373 (2017).
Tubbs, A. & Nussenzweig, A. Endogenous DNA damage as a source of genomic instability in cancer. Cell 168, 644–656 (2017).
McKinnon, P. J. Genome integrity and disease prevention in the nervous system. Genes Dev. 31, 1180–1194 (2017).
Santivasi, W. L. & Xia, F. Ionizing radiation-induced DNA damage, response, and repair. Antioxid. Redox Signal. 21, 251–259 (2014).
Chatterjee, N. & Walker, G. C. Mechanisms of DNA damage, repair, and mutagenesis. Env. Mol. Mutagen. 58, 235–263 (2017).
Stiff, T. et al. ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res. 64, 2390–2396 (2004).
Wang, H., Wang, M., Wang, H., Böcker, W. & Iliakis, G. Complex H2AX phosphorylation patterns by multiple kinases including ATM and DNA-PK in human cells exposed to ionizing radiation and treated with kinase inhibitors. J. Cell Physiol. 202, 492–502 (2005).
Caron, P. et al. Non-redundant functions of ATM and DNA-PKcs in response to DNA double-strand breaks. Cell Rep. 13, 1598–1609 (2015).
Burma, S., Chen, B. P., Murphy, M., Kurimasa, A. & Chen, D. J. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem. 276, 42462–42467 (2001).
Coster, G. & Goldberg, M. The cellular response to DNA damage: a focus on MDC1 and its interacting proteins. Nucleus 1, 166–178 (2010).
Wu, L., Luo, K., Lou, Z. & Chen, J. MDC1 regulates intra-S-phase checkpoint by targeting NBS1 to DNA double-strand breaks. Proc. Natl Acad. Sci. USA 105, 11200–11205 (2008).
Melander, F. et al. Phosphorylation of SDT repeats in the MDC1 N terminus triggers retention of NBS1 at the DNA damage-modified chromatin. J. Cell Biol. 181, 213–226 (2008).
Spycher, C. et al. Constitutive phosphorylation of MDC1 physically links the MRE11-RAD50-NBS1 complex to damaged chromatin. J. Cell Biol. 181, 227–240 (2008).
Shiloh, Y. The cerebellar degeneration in ataxia-telangiectasia: a case for genome instability. DNA Repair. 95, 102950 (2020).
Blackford, A. N. & Jackson, S. P. ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response. Mol. Cell 66, 801–817 (2017).
Symington, L. S. Mechanism and regulation of DNA end resection in eukaryotes. Crit. Rev. Biochem. Mol. Biol. 51, 195–212 (2016).
Marechal, A. & Zou, L. DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb. Perspect. Biol. 5, a012716 (2013).
Kastan, M. B. & Lim, D. The many substrates and functions of ATM. Nat. Rev. Mol. Cell Biol. 1, 179–186 (2000).
Kowalczykowski, S. C. An overview of the molecular mechanisms of recombinational DNA repair. Cold Spring Harb. Perspect. Biol. 7, a016410 (2015).
Sartori, A. A. et al. Human CtIP promotes DNA end resection. Nature 450, 509–514 (2007).
You, Z. et al. CtIP links DNA double-strand break sensing to resection. Mol. Cell 36, 954–969 (2009).
Wang, H. et al. The interaction of CtIP and Nbs1 connects CDK and ATM to regulate HR-mediated double-strand break repair. PLoS Genet. 9, e1003277 (2013).
Peterson, S. E. et al. Activation of DSB processing requires phosphorylation of CtIP by ATR. Mol. Cell 49, 657–667 (2013).
Bolderson, E. et al. Phosphorylation of Exo1 modulates homologous recombination repair of DNA double-strand breaks. Nucleic acids Res. 38, 1821–1831 (2010).
Ababou, M. et al. ATM-dependent phosphorylation and accumulation of endogenous BLM protein in response to ionizing radiation. Oncogene 19, 5955–5963 (2000).
Cortez, D., Wang, Y., Qin, J. & Elledge, S. J. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Science 286, 1162–1166 (1999).
Xu, B., O’Donnell, A. H., Kim, S. T. & Kastan, M. B. Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation. Cancer Res. 62, 4588–4591 (2002).
Gatei, M. et al. Role for ATM in DNA damage-induced phosphorylation of BRCA1. Cancer Res. 60, 3299–3304 (2000).
Ahlskog, J. K., Larsen, B. D., Achanta, K. & Sørensen, C. S. ATM/ATR-mediated phosphorylation of PALB2 promotes RAD51 function. EMBO Rep. 17, 671–681 (2016).
Kijas, A. W. et al. ATM-dependent phosphorylation of MRE11 controls extent of resection during homology directed repair by signalling through exonuclease 1. Nucleic Acids Res. 43, 8352–8367 (2015).
Di Virgilio, M., Ying, C. Y. & Gautier, J. PIKK-dependent phosphorylation of Mre11 induces MRN complex inactivation by disassembly from chromatin. DNA Repair. 8, 1311–1320 (2009).
Zhao, X. et al. Cell cycle-dependent control of homologous recombination. Acta Biochim. Biophys. Sin. 49, 655–668 (2017).
Aylon, Y., Liefshitz, B. & Kupiec, M. The CDK regulates repair of double-strand breaks by homologous recombination during the cell cycle. EMBO J. 23, 4868–4875 (2004).
Ferretti, L. P., Lafranchi, L. & Sartori, A. A. Controlling DNA-end resection: a new task for CDKs. Front. Genet. 4, 99 (2013).
Simoneau, A., Robellet, X., Ladouceur, A.-M. & D’Amours, D. Cdk1-dependent regulation of the Mre11 complex couples DNA repair pathways to cell cycle progression. Cell Cycle 13, 1078–1090 (2014).
Falck, J. et al. CDK targeting of NBS1 promotes DNA-end resection, replication restart and homologous recombination. EMBO Rep. 13, 561–568 (2012).
Buis, J., Stoneham, T., Spehalski, E. & Ferguson, D. O. Mre11 regulates CtIP-dependent double-strand break repair by interaction with CDK2. Nat. Struct. Mol. Biol. 19, 246–252 (2012).
Tomimatsu, N. et al. Phosphorylation of EXO1 by CDKs 1 and 2 regulates DNA end resection and repair pathway choice. Nat. Commun. 5, 3561 (2014).
Huertas, P., Cortes-Ledesma, F., Sartori, A. A., Aguilera, A. & Jackson, S. P. CDK targets Sae2 to control DNA-end resection and homologous recombination. Nature 455, 689–692 (2008).
Huertas, P. & Jackson, S. P. Human CtIP mediates cell cycle control of DNA end resection and double strand break repair. J. Biol. Chem. 284, 9558–9565 (2009).
Chang, H. H. Y., Pannunzio, N. R., Adachi, N. & Lieber, M. R. Non-homologous DNA end joining and alternative pathways to double-strand break repair. Nat. Rev. Mol. Cell Biol. 18, 495–506 (2017).
Yang, G. et al. Super-resolution imaging identifies PARP1 and the Ku complex acting as DNA double-strand break sensors. Nucleic Acids Res. 46, 3446–3457 (2018).
Britton, S., Coates, J. & Jackson, S. P. A new method for high-resolution imaging of Ku foci to decipher mechanisms of DNA double-strand break repair. J. Cell Biol. 202, 579–595 (2013).
Jette, N. & Lees-Miller, S. P. The DNA-dependent protein kinase: A multifunctional protein kinase with roles in DNA double strand break repair and mitosis. Prog. Biophys. Mol. Biol. 117, 194–205 (2015).
Chen, B. P. et al. Ataxia telangiectasia mutated (ATM) is essential for DNA-PKcs phosphorylations at the Thr-2609 cluster upon DNA double strand break. J. Biol. Chem. 282, 6582–6587 (2007).
Riballo, E. et al. A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. Mol. Cell 16, 715–724 (2004).
Goodarzi, A. A. et al. DNA-PK autophosphorylation facilitates Artemis endonuclease activity. EMBO J. 25, 3880–3889 (2006).
Imamichi, S., Sharma, M. K., Kamdar, R. P., Fukuchi, M. & Matsumoto, Y. Ionizing radiation-induced XRCC4 phosphorylation is mediated through ATM in addition to DNA-PK. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 90, 365–372 (2014).
Yu, Y. et al. DNA-PK and ATM phosphorylation sites in XLF/Cernunnos are not required for repair of DNA double strand breaks. DNA Repair. 7, 1680–1692 (2008).
Sastre-Moreno, G. et al. Regulation of human polλ by ATM-mediated phosphorylation during non-homologous end joining. DNA Repair. 51, 31–45 (2017).
Mirman, Z. & de Lange, T. 53BP1: a DSB escort. Genes Dev. 34, 7–23 (2020).
Bothmer, A. et al. Regulation of DNA end joining, resection, and immunoglobulin class switch recombination by 53BP1. Mol. Cell 42, 319–329 (2011).
Chapman, J. R. et al. RIF1 is essential for 53BP1-dependent nonhomologous end joining and suppression of DNA double-strand break resection. Mol. Cell 49, 858–871 (2013).
Feng, L., Fong, K.-W., Wang, J., Wang, W. & Chen, J. RIF1 counteracts BRCA1-mediated end resection during DNA repair. J. Biol. Chem. 288, 11135–11143 (2013).
Zimmermann, M., Lottersberger, F., Buonomo, S. B., Sfeir, A. & de Lange, T. 53BP1 regulates DSB repair using Rif1 to control 5′ end resection. Science 339, 700–704 (2013).
Di Virgilio, M. et al. Rif1 prevents resection of DNA breaks and promotes immunoglobulin class switching. Science 339, 711–715 (2013).
Callen, E. et al. 53BP1 mediates productive and mutagenic DNA repair through distinct phosphoprotein interactions. Cell 153, 1266–1280 (2013).
Bunting, S. F. et al. 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell 141, 243–254 (2010).
Balmus, G. et al. ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks. Nat. Commun. 10, 87 (2019).
Nakamura, K. et al. Proteome dynamics at broken replication forks reveal a distinct ATM-directed repair response suppressing DNA double-strand break ubiquitination. Mol. Cell 81, 1084–1099 (2021).
Britton, S. et al. ATM antagonizes NHEJ proteins assembly and DNA-ends synapsis at single-ended DNA double strand breaks. Nucleic Acids Res. 48, 9710–9723 (2020).
Katsuki, Y., Jeggo, P. A., Uchihara, Y., Takata, M. & Shibata, A. DNA double-strand break end resection: a critical relay point for determining the pathway of repair and signaling. Genome Instab. Dis. 1, 155–171 (2020).
Ceccaldi, R., Rondinelli, B. & D’Andrea, A. D. Repair pathway choices and consequences at the double-strand break. Trends Cell Biol. 26, 52–64 (2016).
Deshpande, R. A. et al. DNA-dependent protein kinase promotes DNA end processing by MRN and CtIP. Sci. Adv. 6, eaay0922 (2020).
Ingram, S. P. et al. Mechanistic modelling supports entwined rather than exclusively competitive DNA double-strand break repair pathway. Sci. Rep. 9, 6359 (2019).
Kakarougkas, A. & Jeggo, P. A. DNA DSB repair pathway choice: an orchestrated handover mechanism. Br. J. Radiol. 87, 20130685 (2014).
Pommier, Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat. Rev. Cancer 6, 789–802 (2006).
Pommier, Y. Drugging topoisomerases: lessons and challenges. ACS Chem. Biol. 8, 82–95 (2013).
Alagoz, M., Chiang, S. C., Sharma, A. & El-Khamisy, S. F. ATM deficiency results in accumulation of DNA-topoisomerase I covalent intermediates in neural cells. PLoS ONE 8, e58239 (2013).
Katyal, S. et al. Aberrant topoisomerase-1 DNA lesions are pathogenic in neurodegenerative genome instability syndromes. Nat. Neurosci. 17, 813–821 (2014).
Das, B. B. et al. Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK. EMBO J. 28, 3667–3680 (2009).
Chiang, S.-C., Carroll, J. & El-Khamisy, S. F. TDP1 serine 81 promotes interaction with DNA ligase IIIalpha and facilitates cell survival following DNA damage. Cell Cycle 9, 588–595 (2010).
Yamamoto, K. et al. Kinase-dead ATM protein is highly oncogenic and can be preferentially targeted by Topo-isomerase I inhibitors. eLife 5, e14709 (2016).
Yamamoto, K. et al. Kinase-dead ATM protein causes genomic instability and early embryonic lethality in mice. J. Cell Biol. 198, 305–313 (2012).
Daniel, J. A. et al. Loss of ATM kinase activity leads to embryonic lethality in mice. J. Cell Biol. 198, 295–304 (2012).
Pommier, Y., Leo, E., Zhang, H. & Marchand, C. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem. Biol. 17, 421–433 (2010).
Pommier, Y. et al. Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2). DNA Repair 19, 114–129 (2014).
Álvarez-Quilón, A. et al. ATM specifically mediates repair of double-strand breaks with blocked DNA ends. Nat. Commun. 5, 3347 (2014).
Álvarez-Quilón, A. et al. Endogenous topoisomerase II-mediated DNA breaks drive thymic cancer predisposition linked to ATM deficiency. Nat. Commun. 11, 910 (2020).
Tamaichi, H. et al. Ataxia telangiectasia mutated-dependent regulation of topoisomerase II alpha expression and sensitivity to topoisomerase II inhibitor. Cancer Sci. 104, 178–184 (2013).
Hoa, N. N. et al. Mre11 Is essential for the removal of lethal topoisomerase 2 covalent cleavage complexes. Mol. Cell 64, 580–592 (2016).
Yamaguchi-Iwai, Y. et al. Mre11 is essential for the maintenance of chromosomal DNA in vertebrate cells. EMBO J. 18, 6619–6629 (1999).
Lee, K. C. et al. MRE11 facilitates the removal of human topoisomerase II complexes from genomic DNA. Biol. Open 1, 863–873 (2012).
Aparicio, T., Baer, R., Gottesman, M. & Gautier, J. MRN, CtIP, and BRCA1 mediate repair of topoisomerase II-DNA adducts. J. Cell Biol. 212, 399–408 (2016).
Keeney, S. & Neale, M. J. Initiation of meiotic recombination by formation of DNA double-strand breaks: mechanism and regulation. Biochemical Soc. Trans. 34, 523–525 (2006).
Chanut, P., Britton, S., Coates, J., Jackson, S. P. & Calsou, P. Coordinated nuclease activities counteract Ku at single-ended DNA double-strand breaks. Nat. Commun. 7, 12889 (2016).
Lee, J.-H., Ryu, S. W., Ender, N. A., Paull, T. T. & Paull, T. T. Poly-ADP-ribosylation drives loss of protein homeostasis in ATM and Mre11 deficiency. Mol. Cell 81, 1515–1533 (2021).
Chou, W.-C. et al. Chk2-dependent phosphorylation of XRCC1 in the DNA damage response promotes base excision repair. EMBO J. 27, 3140–3150 (2008).
Jiang, B., Glover, J. N. & Weinfeld, M. Neurological disorders associated with DNA strand-break processing enzymes. Mech. Ageing Dev. 161, 130–140 (2017).
Hoch, N. C. et al. XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia. Nature 541, 87–91 (2017).
Yoon, G. & Caldecott, K. W. Nonsyndromic cerebellar ataxias associated with disorders of DNA single-strand break repair. Handb. Clin. Neurol. 155, 105–115 (2018).
Muñoz, M. J. et al. DNA damage regulates alternative splicing through inhibition of RNA polymerase II elongation. Cell 137, 708–720 (2009).
Nicholls, C. D., Shields, M. A., Lee, P. W. K., Robbins, S. M. & Beattie, T. L. UV-dependent alternative splicing uncouples p53 activity and PIG3 gene function through rapid proteolytic degradation. J. Biol. Chem. 279, 24171–24178 (2004).
Su, C. et al. RUG3 and ATM synergistically regulate the alternative splicing of mitochondrial nad2 and the DNA damage response in Arabidopsis thaliana. Sci. Rep. 7, 43897 (2017).
Niehrs, C. & Luke, B. Regulatory R-loops as facilitators of gene expression and genome stability. Nat. Rev. Mol. Cell Biol. 21, 167–178 (2020).
Yeo, A. J. et al. R-loops in proliferating cells but not in the brain: implications for AOA2 and other autosomal recessive ataxias. PLoS ONE 9, e90219 (2014).
Hamperl, S., Bocek, M. J., Saldivar, J. C., Swigut, T. & Cimprich, K. A. Transcription-replication conflict orientation modulates R-loop levels and activates distinct DNA damage responses. Cell 170, 774–786.e19 (2017).
Marabitti, V. et al. ATM pathway activation limits R-loop-associated genomic instability in Werner syndrome cells. Nucleic Acids Res. 47, 3485–3502 (2019).
Sollier, J. et al. Transcription-coupled nucleotide excision repair factors promote R-loop-induced genome instability. Mol. Cell 56, 777–785 (2014).
Yasuhara, T. et al. Human Rad52 promotes XPG-mediated R-loop processing to initiate transcription-associated homologous recombination repair. Cell 175, 558–570.e11 (2018).
Cristini, A. et al. Dual processing of R-Loops and topoisomerase I induces transcription-dependent DNA double-strand breaks. Cell Rep. 28, 3167–3181.e6 (2019).
Makharashvili, N. et al. Sae2/CtIP prevents R-loop accumulation in eukaryotic cells. eLife 7, e42733 (2018).
Yüce, Ö. & West, S. C. Senataxin, defective in the neurodegenerative disorder ataxia with oculomotor apraxia 2, lies at the interface of transcription and the DNA damage response. Mol. Cell. Biol. 33, 406–417 (2013).
Singh, A., Kukreti, R., Saso, L. & Kukreti, S. Oxidative stress: a key modulator in neurodegenerative diseases. Molecules 24, 1583 (2019).
Watts, M. E., Pocock, R. & Claudianos, C. Brain energy and oxygen metabolism: emerging role in normal function and disease. Front. Mol. Neurosci. 11, 216 (2018).
Gandhi, S. & Abramov, A. Y. Mechanism of oxidative stress in neurodegeneration. Oxid. Med. Cell. Longev. 2012, 1–11 (2012).
Cenini, G., Lloret, A. & Cascella, R. Oxidative stress in neurodegenerative diseases: from a mitochondrial point of view. Oxid. Med. Cell. Longev. 2019, 2105607 (2019).
Barzilai, A., Rotman, G. & Shiloh, Y. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair. 1, 3–25 (2002).
Quick, K. L. & Dugan, L. L. Superoxide stress identifies neurons at risk in a model of ataxia-telangiectasia. Ann. Neurol. 49, 627–635 (2001).
Pietrucha, B. et al. Comparison of selected parameters of redox homeostasis in patients with ataxia-telangiectasia and nijmegen breakage syndrome. Oxid. Med. Cell Longev. 2017, 6745840 (2017).
Kamsler, A. et al. Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. Cancer Res. 61, 1849–1854 (2001).
Liu, N. et al. ATM deficiency induces oxidative stress and endoplasmic reticulum stress in astrocytes. Lab. Invest. 85, 1471–1480 (2005).
Takao, N., Li, Y. & Yamamoto, K. Protective roles for ATM in cellular response to oxidative stress. FEBS Lett. 472, 133–136 (2000).
Watters, D. J. Oxidative stress in ataxia telangiectasia. Redox Rep. 8, 23–29 (2003).
Reichenbach, J. et al. Elevated oxidative stress in patients with ataxia telangiectasia. Antioxid. Redox Signal. 4, 465–469 (2002).
Reichenbach, J. et al. Anti-oxidative capacity in patients with ataxia telangiectasia. Clin. Exp. Immunol. 117, 535–539 (1999).
Semlitsch, M., Shackelford, R. E., Zirkl, S., Sattler, W. & Malle, E. ATM protects against oxidative stress induced by oxidized low-density lipoprotein. DNA Repair 10, 848–860 (2011).
Yeo, A. J. et al. Loss of ATM in airway epithelial cells is associated with susceptibility to oxidative stress. Am. J. Respir. Crit. Care Med. 196, 391–393 (2017).
Mosesso, P., Piane, M., Pepe, G., Cinelli, S. & Chessa, L. Modulation of hypersensitivity to oxidative DNA damage in ATM defective cells induced by potassium bromate by inhibition of the poly (ADP-ribose) polymerase (PARP). Mutat. Res. Genetic Toxicol. Environ. Mutagen. 836, 117–123 (2018).
Ehrenfeld, V., Heusel, J. R., Fulda, S. & van Wijk, S. J. L. ATM inhibition enhances Auranofin-induced oxidative stress and cell death in lung cell lines. PLoS ONE 15, e0244060 (2020).
Kim, J. & Wong, P. K. Oxidative stress is linked to ERK1/2-p16 signaling-mediated growth defect in ATM-deficient astrocytes. J. Biol. Chem. 284, 14396–14404 (2009).
Chessa, L. et al. Heterogeneity in ataxia-telangiectasia: classical phenotype associated with intermediate cellular radiosensitivity. Am. J. Med. Genet. 42, 741–746 (1992).
Gilad, S. et al. Genotype-phenotype relationships in ataxia-telangiectasia and variants. Am. J. Hum. Genet. 62, 551–561 (1998).
Toyoshima, M. et al. Ataxia-telangiectasia without immunodeficiency: novel point mutations within and adjacent to the phosphatidylinositol 3-kinase-like domain. Am. J. Med. Genet. 75, 141–144 (1998).
Barlow, C. et al. Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc. Natl Acad. Sci. USA 96, 9915–9919 (1999).
Kuljis, R. O., Xu, Y., Aguila, M. C. & Baltimore, D. Degeneration of neurons, synapses, and neuropil and glial activation in a murine Atm knockout model of ataxia-telangiectasia. Proc. Natl Acad. Sci. USA 94, 12688–12693 (1997).
Barlow, C. et al. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86, 159–171 (1996).
Bishop, A. J., Barlow, C., Wynshaw-Boris, A. J. & Schiestl, R. H. Atm deficiency causes an increased frequency of intrachromosomal homologous recombination in mice. Cancer Res. 60, 395–399 (2000).
Xu, Y. et al. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 10, 2411–2422 (1996).
Schubert, R. et al. Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice. Hum. Mol. Genet. 13, 1793–1802 (2004).
Reliene, R. & Schiestl, R. H. Antioxidant N-acetyl cysteine reduces incidence and multiplicity of lymphoma in Atm deficient mice. DNA Repair 5, 852–859 (2006).
Ito, K. et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431, 997–1002 (2004).
Kim, J. & Wong, P. K. Y. Loss of ATM impairs proliferation of neural stem cells through oxidative stress-mediated p38 MAPK signaling. Stem Cell 27, 1987–1998 (2009).
Watters, D. et al. Localization of a portion of extranuclear ATM to peroxisomes. J. Biol. Chem. 274, 34277–34282 (1999).
Zhang, J. et al. ATM functions at the peroxisome to induce pexophagy in response to ROS. Nat. Cell Biol. 17, 1259–1269 (2015).
Lim, D. S. et al. ATM binds to beta-adaptin in cytoplasmic vesicles. Proc. Natl Acad. Sci. USA 95, 10146–10151 (1998).
Valentin-Vega, Y. A. et al. Mitochondrial dysfunction in ataxia-telangiectasia. Blood 119, 1490–1500 (2012).
Watters, D. et al. Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms. Oncogene 14, 1911–1921 (1997).
Blignaut, M., Loos, B., Botchway, S. W., Parker, A. W. & Huisamen, B. Ataxia-telangiectasia mutated is located in cardiac mitochondria and impacts oxidative phosphorylation. Sci. Rep. 9, 4782 (2019).
Li, J., Han, Y. R., Plummer, M. R. & Herrup, K. Cytoplasmic ATM in neurons modulates synaptic function. Curr. Biol. 19, 2091–2096 (2009).
Barlow, C. et al. ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation. Proc. Natl Acad. Sci. USA 97, 871–876 (2000).
Oka, A. & Takashima, S. Expression of the ataxia-telangiectasia gene (ATM) product in human cerebellar neurons during development. Neurosci. Lett. 252, 195–198 (1998).
Kuljis, R. O., Chen, G., Lee, E. Y., Aguila, M. C. & Xu, Y. ATM immunolocalization in mouse neuronal endosomes: implications for ataxia-telangiectasia. Brain Res. 842, 351–358 (1999).
Vail, G. et al. ATM protein is located on presynaptic vesicles and its deficit leads to failures in synaptic plasticity. J. Neurophysiol. 116, 201–209 (2016).
Hadian, K. & Krappmann, D. Signals from the nucleus: activation of NF-kappaB by cytosolic ATM in the DNA damage response. Sci. Signal. 4, pe2 (2011).
Wu, Z.-H., Shi, Y., Tibbetts, R. S. & Miyamoto, S. Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science 311, 1141–1146 (2006).
Hinz, M. et al. A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-κB activation. Mol. Cell 40, 63–74 (2010).
Miyamoto, S. Nuclear initiated NF-kappaB signaling: NEMO and ATM take center stage. Cell Res. 21, 116–130 (2011).
Wu, G. et al. An ATM/TRIM37/NEMO axis counteracts genotoxicity by activating nuclear-to-cytoplasmic NF-κB signaling. Cancer Res. 78, 6399–6412 (2018).
Fang, L. et al. ATM regulates NF-κB-dependent immediate-early genes via RelA Ser 276 phosphorylation coupled to CDK9 promoter recruitment. Nucleic Acids Res. 42, 8416–8432 (2014).
Nolfi-Donegan, D., Braganza, A. & Shiva, S. Mitochondrial electron transport chain: Oxidative phosphorylation, oxidant production, and methods of measurement. Redox Biol. 37, 101674 (2020).
Zhao, R.-Z., Jiang, S., Zhang, L. & Yu, Z.-B. Mitochondrial electron transport chain, ROS generation and uncoupling (Review). Int. J. Mol. Med. 44, 3–15 (2019).
Smith, E. F., Shaw, P. J. & De Vos, K. J. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci. Lett. 710, 132933 (2019).
Winklhofer, K. F. & Haass, C. Mitochondrial dysfunction in Parkinson’s disease. Biochim. Biophys. Acta 1802, 29–44 (2010).
Carmo, C., Naia, L., Lopes, C. & Rego, A. C. Mitochondrial dysfunction in Huntington’s disease. Adv. Exp. Med. Biol. 1049, 59–83 (2018).
Lee, J.-H. & Paull, T. T. Mitochondria at the crossroads of ATM-mediated stress signaling and regulation of reactive oxygen species. Redox Biol. 32, 101511 (2020).
Eaton, J. S., Lin, Z. P., Sartorelli, A. C., Bonawitz, N. D. & Shadel, G. S. Ataxia-telangiectasia mutated kinase regulates ribonucleotide reductase and mitochondrial homeostasis. J. Clin. Invest. 117, 2723–2734 (2007).
Ambrose, M., Goldstine, J. V. & Gatti, R. A. Intrinsic mitochondrial dysfunction in ATM-deficient lymphoblastoid cells. Hum. Mol. Genet. 16, 2154–2164 (2007).
Fang, E. F. et al. NAD+ replenishment improves lifespan and healthspan in ataxia telangiectasia models via mitophagy and DNA repair. Cell Metab. 24, 566–581 (2016).
Weyemi, U. et al. Histone H2AX deficiency causes neurobehavioral deficits and impaired redox homeostasis. Nat. Commun. 9, 1526 (2018).
Weyemi, U. et al. Histone H2AX promotes neuronal health by controlling mitochondrial homeostasis. Proc. Natl Acad. Sci. USA 116, 7471–7476 (2019).
Zha, S., Sekiguchi, J., Brush, J. W., Bassing, C. H. & Alt, F. W. Complementary functions of ATM and H2AX in development and suppression of genomic instability. Proc. Natl Acad. Sci. USA 105, 9302–9306 (2008).
Sarkar, A. & Gandhi, V. Activation of ATM kinase by ROS generated during ionophore-induced mitophagy in human T and B cell malignancies. Mol. Cell. Biochem. 476, 417–423 (2020).
Cirotti, C. et al. Redox activation of ATM enhances GSNOR translation to sustain mitophagy and tolerance to oxidative stress. EMBO Rep. 22, e50500 (2021).
Rizza, S. et al. S-nitrosylation drives cell senescence and aging in mammals by controlling mitochondrial dynamics and mitophagy. Proc. Natl Acad. Sci. USA 115, E3388–E3397 (2018).
Rizza, S. & Filomeni, G. Denitrosylate and live longer: how ADH5/GSNOR links mitophagy to aging. Autophagy 14, 1285–1287 (2018).
Guo, Q.-Q. et al. ATM-CHK2-Beclin 1 axis promotes autophagy to maintain ROS homeostasis under oxidative stress. EMBO J. 39, e103111 (2020).
Criddle, D. N. et al. Menadione-induced reactive oxygen species generation via redox cycling promotes apoptosis of murine pancreatic acinar cells. J. Biol. Chem. 281, 40485–40492 (2006).
Tassinari, V. et al. Atrophy, oxidative switching and ultrastructural defects in skeletal muscle of the ataxia telangiectasia mouse model. J. Cell Sci. 132, jcs223008 (2019).
Agathanggelou, A. et al. Targeting the ataxia telangiectasia mutated-null phenotype in chronic lymphocytic leukemia with pro-oxidants. Haematologica 100, 1076–1085 (2015).
Schroeder, E. A., Raimundo, N. & Shadel, G. S. Epigenetic silencing mediates mitochondria stress-induced longevity. Cell Metab. 17, 954–964 (2013).
Pan, Y. & Shadel, G. S. Extension of chronological life span by reduced TOR signaling requires down-regulation of Sch9p and involves increased mitochondrial OXPHOS complex density. Aging 1, 131–145 (2009).
Rieusset, J. The role of endoplasmic reticulum-mitochondria contact sites in the control of glucose homeostasis: an update. Cell Death Dis. 9, 388 (2018).
Rodríguez, L. R. et al. Oxidative stress modulates rearrangement of endoplasmic reticulum-mitochondria contacts and calcium dysregulation in a Friedreich’s ataxia model. Redox Biol. 37, 101762 (2020).
Fernandez-Marcos, P. J. & Nóbrega-Pereira, S. NADPH: new oxygen for the ROS theory of aging. Oncotarget 7, 50814–50815 (2016).
Chen, J. et al. The impact of glutamine supplementation on the symptoms of ataxia-telangiectasia: a preclinical assessment. Mol. Neurodegener. 11, 60 (2016).
Peng, M. et al. Intracellular citrate accumulation by oxidized ATM-mediated metabolism reprogramming via PFKP and CS enhances hypoxic breast cancer cell invasion and metastasis. Cell Death Dis. 10, 228 (2019).
Bencokova, Z. et al. ATM activation and signaling under hypoxic conditions. Mol. Cell Biol. 29, 526–537 (2009).
Lindahl, T. & Barnes, D. E. Repair of endogenous DNA damage. Cold Spring Harb. Symp. Quant. Biol. 65, 127–133 (2000).
Reliene, R., Fischer, E. & Schiestl, R. H. Effect of N-acetyl cysteine on oxidative DNA damage and the frequency of DNA deletions in atm-deficient mice. Cancer Res. 64, 5148–5153 (2004).
Weyemi, U. et al. NADPH oxidase 4 is a critical mediator in ataxia telangiectasia disease. Proc. Natl Acad. Sci. USA 112, 2121–2126 (2015).
Pommier, Y. et al. Repair of topoisomerase I-mediated DNA damage. Prog. Nucleic Acid. Res. Mol. Biol. 81, 179–229 (2006).
Ito, K. et al. Regulation of reactive oxygen species by Atm is essential for proper response to DNA double-strand breaks in lymphocytes. J. Immunol. 178, 103–110 (2007).
Ray Chaudhuri, A. & Nussenzweig, A. The multifaceted roles of PARP1 in DNA repair and chromatin remodelling. Nat. Rev. Mol. Cell Biol. 18, 610–621 (2017).
Gupte, R., Liu, Z. & Kraus, W. L. PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes. Genes Dev. 31, 101–126 (2017).
Liu, C., Vyas, A., Kassab, M. A., Singh, A. K. & Yu, X. The role of poly ADP-ribosylation in the first wave of DNA damage response. Nucleic Acids Res. 45, 8129–8141 (2017).
El-Khamisy, S. F., Masutani, M., Suzuki, H. & Caldecott, K. W. A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage. Nucleic Acids Res. 31, 5526–5533 (2003).
Mortusewicz, O., Amé, J.-C., Schreiber, V. & Leonhardt, H. Feedback-regulated poly(ADP-ribosyl)ation by PARP-1 is required for rapid response to DNA damage in living cells. Nucleic Acids Res. 35, 7665–7675 (2007).
Bonfiglio, J. J. et al. Serine ADP-ribosylation depends on HPF1. Mol. Cell 65, 932–940.e6 (2017).
Gibbs-Seymour, I., Fontana, P., Rack, J. G. M. & Ahel, I. HPF1/C4orf27 is a PARP-1-interacting protein that regulates PARP-1 ADP-ribosylation activity. Mol. Cell 62, 432–442 (2016).
Suskiewicz, M. J. et al. HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation. Nature 579, 598–602 (2020).
Larsen, S. C., Hendriks, I. A., Lyon, D., Jensen, L. J. & Nielsen, M. L. Systems-wide analysis of serine ADP-ribosylation reveals widespread occurrence and site-specific overlap with phosphorylation. Cell Rep. 24, 2493–2505.e4 (2018).
Abplanalp, J. et al. Proteomic analyses identify ARH3 as a serine mono-ADP-ribosylhydrolase. Nat. Commun. 8, 2055 (2017).
Slade, D. et al. The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase. Nature 477, 616–620 (2011).
Gassman, N. R., Stefanick, D. F., Kedar, P. S., Horton, J. K. & Wilson, S. H. Hyperactivation of PARP triggers nonhomologous end-joining in repair-deficient mouse fibroblasts. PLoS ONE 7, e49301 (2012).
Demin, A. A. et al. XRCC1 prevents toxic PARP1 trapping during DNA base excision repair. Mol. Cell 81, 3018–3030 (2021).
Koh, D. W. et al. Failure to degrade poly(ADP-ribose) causes increased sensitivity to cytotoxicity and early embryonic lethality. Proc. Natl Acad. Sci. USA 101, 17699–17704 (2004).
Hanai, S. et al. Loss of poly(ADP-ribose) glycohydrolase causes progressive neurodegeneration in Drosophila melanogaster. Proc. Natl Acad. Sci. USA 101, 82–86 (2004).
Horton, J. K., Stefanick, D. F. & Wilson, S. H. Involvement of poly(ADP-ribose) polymerase activity in regulating Chk1-dependent apoptotic cell death. DNA Repair. 4, 1111–1120 (2005).
Alano, C. C. et al. NAD+ depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death. J. Neurosci. 30, 2967–2978 (2010).
Wang, Y. et al. Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos). Sci. Signal. 4, ra20 (2011).
David, K. K., Andrabi, S. A., Dawson, T. M. & Dawson, V. L. Parthanatos, a messenger of death. Front. Biosci. 14, 1116–1128 (2009).
Andrabi, S. A. et al. Poly(ADP-ribose) (PAR) polymer is a death signal. Proc. Natl Acad. Sci. USA 103, 18308–18313 (2006).
Martire, S., Mosca, L. & d’Erme, M. PARP-1 involvement in neurodegeneration: a focus on Alzheimer’s and Parkinson’s diseases. Mech. Ageing Dev. 146–148, 53–64 (2015).
Abeti, R. & Duchen, M. R. Activation of PARP by oxidative stress induced by β-amyloid: implications for Alzheimer’s disease. Neurochem. Res. 37, 2589–2596 (2012).
Lee, Y. et al. Poly (ADP-ribose) in the pathogenesis of Parkinson’s disease. BMB Rep. 47, 424–432 (2014).
Kam, T.-I. et al. Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson’s disease. Science 362, eaat8407 (2018).
Puentes, L. N. et al. Poly (ADP-ribose) induces α-synuclein aggregation in neuronal-like cells and interacts with phosphorylated α-synuclein in post mortem PD samples. bioRxiv https://doi.org/10.1101/2020.04.08.032250 (2020).
Leung, A. K. L. Poly(ADP-ribose): a dynamic trigger for biomolecular condensate formation. Trends Cell Biol. 30, 370–383 (2020).
Mastrocola, A. S., Kim, S. H., Trinh, A. T., Rodenkirch, L. A. & Tibbetts, R. S. The RNA-binding protein fused in sarcoma (FUS) functions downstream of poly(ADP-ribose) polymerase (PARP) in response to DNA damage. J. Biol. Chem. 288, 24731–24741 (2013).
Altmeyer, M. et al. Liquid demixing of intrinsically disordered proteins is seeded by poly(ADP-ribose). Nat. Commun. 6, 8088 (2015).
Singatulina, A. S. et al. PARP-1 activation directs FUS to DNA damage sites to form PARG-reversible compartments enriched in damaged DNA. Cell Rep. 27, 1809–1821.e5 (2019).
Patel, A. et al. A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell 162, 1066–1077 (2015).
Chen, J.-K., Lin, W.-L., Chen, Z. & Liu, H.-W. PARP-1-dependent recruitment of cold-inducible RNA-binding protein promotes double-strand break repair and genome stability. Proc. Natl Acad. Sci. USA 115, E1759–E1768 (2018).
Duan, Y. et al. PARylation regulates stress granule dynamics, phase separation, and neurotoxicity of disease-related RNA-binding proteins. Cell Res. 29, 233–247 (2019).
Banani, S. F., Lee, H. O., Hyman, A. A. & Rosen, M. K. Biomolecular condensates: organizers of cellular biochemistry. Nat. Rev. Mol. Cell Biol. 18, 285–298 (2017).
Kim, D.-S., Challa, S., Jones, A. & Kraus, W. L. PARPs and ADP-ribosylation in RNA biology: from RNA expression and processing to protein translation and proteostasis. Genes Dev. 34, 302–320 (2020).
Aarum, J. et al. Enzymatic degradation of RNA causes widespread protein aggregation in cell and tissue lysates. EMBO Rep. 21, e4958 (2020).
Gitler, A. D. & Shorter, J. RNA-binding proteins with prion-like domains in ALS and FTLD-U. Prion 5, 179–187 (2011).
Schwartz, J. C., Cech, T. R. & Parker, R. R. Biochemical properties and biological functions of FET proteins. Annu. Rev. Biochem. 84, 355–379 (2015).
Dutertre, M., Lambert, S., Carreira, A., Amor-Guéret, M. & Vagner, S. DNA damage: RNA-binding proteins protect from near and far. Trends Biochem. Sci. 39, 141–149 (2014).
Caldecott, K. W. DNA single-strand break repair and spinocerebellar ataxia. Cell 112, 7–10 (2003).
El-Khamisy, S. F. et al. Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1. Nature 434, 108–113 (2005).
Lévy, E. et al. Causative links between protein aggregation and oxidative stress: a review. Int. J. Mol. Sci. 20, 3896 (2019).
Poletto, M. et al. Modulation of proteostasis counteracts oxidative stress and affects DNA base excision repair capacity in ATM-deficient cells. Nucleic Acids Res. 45, 10042–10055 (2017).
Wood, L. M. et al. A novel role for ATM in regulating proteasome-mediated protein degradation through suppression of the ISG15 conjugation pathway. PLoS ONE 6, e16422 (2011).
Gardiner, M., Toth, R., Vandermoere, F., Morrice, N. A. & Rouse, J. Identification and characterization of FUS/TLS as a new target of ATM. Biochem. J. 415, 297–307 (2008).
Deng, Q. et al. FUS is phosphorylated by DNA-PK and accumulates in the cytoplasm after DNA damage. J. Neurosci. 34, 7802–7813 (2014).
Rhoads, S. N. et al. The prionlike domain of FUS is multiphosphorylated following DNA damage without altering nuclear localization. Mol. Biol. Cell 29, 1786–1797 (2018).
Monahan, Z. et al. Phosphorylation of the FUS low-complexity domain disrupts phase separation, aggregation, and toxicity. EMBO J. 36, 2951–2967 (2017).
Polo, S. E. & Jackson, S. P. Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. Genes Dev. 25, 409–433 (2011).
Saez, I. & Vilchez, D. The mechanistic links between proteasome activity, aging and age-related diseases. Curr. Genomics 15, 38–51 (2014).
Sweeney, P. et al. Protein misfolding in neurodegenerative diseases: implications and strategies. Transl. Neurodegener. 6, 6 (2017).
Dasuri, K., Zhang, L. & Keller, J. N. Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. Free Radic. Biol. Med. 62, 170–185 (2013).
Naumann, M. et al. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat. Commun. 9, 335 (2018).
Wang, W.-Y. et al. Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons. Nat. Neurosci. 16, 1383–1391 (2013).
Walker, C. et al. C9orf72 expansion disrupts ATM-mediated chromosomal break repair. Nat. Neurosci. 20, 1225–1235 (2017).
Gandhi, J. et al. Protein misfolding and aggregation in neurodegenerative diseases: a review of pathogeneses, novel detection strategies, and potential therapeutics. Rev. Neurosci. 30, 339–358 (2019).
Olzscha, H. et al. Amyloid-like aggregates sequester numerous metastable proteins with essential. Cell. Functions. Cell 144, 67–78 (2011).
Cardinale, A. et al. Sublethal doses of β-amyloid peptide abrogate DNA-dependent protein kinase activity. J. Biol. Chem. 287, 2618–2631 (2012).
Ménisser-de Murcia, J., Mark, M., Wendling, O., Wynshaw-Boris, A. & de Murcia, G. Early embryonic lethality in PARP-1 Atm double-mutant mice suggests a functional synergy in cell proliferation during development. Mol. Cell Biol. 21, 1828–1832 (2001).
Pommier, Y., O’Connor, M. J. & de Bono, J. Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action. Sci. Transl. Med. 8, 362ps17 (2016).
Choy, K. R. & Watters, D. J. Neurodegeneration in ataxia-telangiectasia: multiple roles of ATM kinase in cellular homeostasis: ATM and cellular homeostasis. Dev. Dyn. 247, 33–46 (2018).
Ambrose, M. & Gatti, R. A. Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions. Blood 121, 4036–4045 (2013).
Shiloh, Y. & Lederman, H. M. Ataxia-telangiectasia (A-T): an emerging dimension of premature ageing. Ageing Res. Rev. 33, 76–88 (2017).
Klockgether, T., Mariotti, C. & Paulson, H. L. Spinocerebellar ataxia. Nat. Rev. Dis. Prim. 5, 24 (2019).
Paulson, H. L. et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 19, 333–344 (1997).
Holmberg, M. Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum. Mol. Genet. 7, 913–918 (1998).
Orr, H. T. Cell biology of spinocerebellar ataxia. J. Cell Biol. 197, 167–177 (2012).
Sullivan, R., Yau, W. Y., O’Connor, E. & Houlden, H. Spinocerebellar ataxia: an update. J. Neurol. 266, 533–544 (2019).
Dourlen, P., Kilinc, D., Malmanche, N., Chapuis, J. & Lambert, J.-C. The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? Acta Neuropathol. 138, 221–236 (2019).
Tada, M., Nishizawa, M. & Onodera, O. Roles of inositol 1,4,5-trisphosphate receptors in spinocerebellar ataxias. Neurochem. Int. 94, 1–8 (2016).
Shimobayashi, E. & Kapfhammer, J. P. Calcium signaling, PKC gamma, IP3R1 and CAR8 link spinocerebellar ataxias and purkinje cell dendritic development. Curr. Neuropharmacol. 16, 151–159 (2018).
Kasumu, A. & Bezprozvanny, I. Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias. Cerebellum 11, 630–639 (2012).
Chen, X. et al. Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3. J. Neurosci. 28, 12713–12724 (2008).
Chen, D.-H. et al. Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia. Am. J. Hum. Genet. 72, 839–849 (2003).
Tamarit, J. et al. Mitochondrial iron and calcium homeostasis in Friedreich ataxia. IUBMB Life 73, 543–553 (2021).
Abeti, R., Brown, A. F., Maiolino, M., Patel, S. & Giunti, P. Calcium deregulation: novel insights to understand Friedreich’s ataxia pathophysiology. Front. Cell. Neurosci.12, 264 (2018).
Kim, J., Kim, K., Mo, J.-S. & Lee, Y. Atm deficiency in the DNA polymerase β null cerebellum results in cerebellar ataxia and Itpr1 reduction associated with alteration of cytosine methylation. Nucleic Acids Res. 48, 3678–3691 (2020).
Honrath, B. et al. Glucose-regulated protein 75 determines ER–mitochondrial coupling and sensitivity to oxidative stress in neuronal cells. Cell Death Discov. 3, 17076 (2017).
Famulski, K. S. & Paterson, M. C. Defective regulation of Ca2+/calmodulin-dependent protein kinase II in gamma-irradiated ataxia telangiectasia fibroblasts. FEBS Lett. 453, 183–186 (1999).
Famulski, K. S. et al. Aberrant sensing of extracellular Ca2+ by cultured ataxia telangiectasia fibroblasts. Oncogene 22, 471–475 (2003).
Khanna, K. K. et al. Defective signaling through the B cell antigen receptor in Epstein-Barr virus-transformed ataxia-telangiectasia cells. J. Biol. Chem. 272, 9489–9495 (1997).
Yorek, M. A. et al. Abnormal myo-inositol and phospholipid metabolism in cultured fibroblasts from patients with ataxia telangiectasia. Biochim. Biophys. Acta 1437, 287–300 (1999).
Kondo, N. et al. Defective calcium-dependent signal transduction in T lymphocytes of ataxia-telangiectasia. Scand. J. Immunol. 38, 45–48 (1993).
Chiesa, N., Barlow, C., Wynshaw-Boris, A., Strata, P. & Tempia, F. Atm-deficient mice Purkinje cells show age-dependent defects in calcium spike bursts and calcium currents. Neuroscience 96, 575–583 (2000).
Dugger, B. N. & Dickson, D. W. Pathology of neurodegenerative diseases. Cold Spring Harb. Perspect. Biol. 9, a028035 (2017).
Araki, K. et al. Parkinson’s disease is a type of amyloidosis featuring accumulation of amyloid fibrils of α-synuclein. Proc. Natl Acad. Sci. USA 116, 17963–17969 (2019).
Dias, V., Junn, E. & Mouradian, M. M. The role of oxidative stress in Parkinson’s disease. J. Parkinsons Dis. 3, 461–491 (2013).
Kumar, A. & Ratan, R. R. Oxidative stress and Huntington’s disease: the good, the bad, and the ugly. J. Huntingtons Dis. 5, 217–237 (2016).
Buratti, E. & Baralle, F. E. TDP-43: gumming up neurons through protein-protein and protein-RNA interactions. Trends Biochem. Sci. 37, 237–247 (2012).
Soto, C. & Pritzkow, S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat. Neurosci. 21, 1332–1340 (2018).
Mulligan, V. K. & Chakrabartty, A. Protein misfolding in the late-onset neurodegenerative diseases: common themes and the unique case of amyotrophic lateral sclerosis. Proteins 81, 1285–1303 (2013).
Gitler, A. D., Dhillon, P. & Shorter, J. Neurodegenerative disease: models, mechanisms, and a new hope. Dis. Model. Mech. 10, 499–502 (2017).
Lavin, M. F. The appropriateness of the mouse model for ataxia-telangiectasia: neurological defects but no neurodegeneration. DNA Repair. 12, 612–619 (2013).
Beraldi, R. et al. A novel porcine model of ataxia telangiectasia reproduces neurological features and motor deficits of human disease. Hum. Mol. Genet. 24, 6473–6484 (2015).
Rimkus, S. A. & Wassarman, D. A. A pharmacological screen for compounds that rescue the developmental lethality of a Drosophila ATM mutant. PLoS ONE 13, e0190821 (2018).
Quek, H. et al. A rat model of ataxia-telangiectasia: evidence for a neurodegenerative phenotype. Hum. Mol. Genet. 26, 109–123 (2017).
Quek, H. et al. Rats with a missense mutation in Atm display neuroinflammation and neurodegeneration subsequent to accumulation of cytosolic DNA following unrepaired DNA damage. J. Leukoc. Biol. 101, 927–947 (2017).
Eilam, R. et al. Selective loss of dopaminergic nigro-striatal neurons in brains of Atm-deficient mice. Proc. Natl Acad. Sci. USA 95, 12653–12656 (1998).
Levine-Small, N. et al. Reduced synchronization persistence in neural networks derived from atm-deficient mice. Front. Neurosci. 5, 46 (2011).
Kanner, S. et al. Astrocytes restore connectivity and synchronization in dysfunctional cerebellar networks. Proc. Natl Acad. Sci. USA 115, 8025–8030 (2018).
Meshulam, L. et al. The role of the neuro-astro-vascular unit in the etiology of ataxia telangiectasia. Front. Pharmacol. 3, 157 (2012).
Browne, S. E. et al. Treatment with a catalytic antioxidant corrects the neurobehavioral defect in ataxia-telangiectasia mice. Free Radic. Biol. Med. 36, 938–942 (2004).
Gueven, N. et al. Dramatic extension of tumor latency and correction of neurobehavioral phenotype in Atm-mutant mice with a nitroxide antioxidant. Free. Radic. Biol. Med. 41, 992–1000 (2006).
Li, J. et al. EZH2-mediated H3K27 trimethylation mediates neurodegeneration in ataxia-telangiectasia. Nat. Neurosci. 16, 1745–1753 (2013).
Han, S. S. W., Williams, L. A. & Eggan, K. C. Constructing and deconstructing stem cell models of neurological disease. Neuron 70, 626–644 (2011).
Chang, C.-Y. et al. Induced pluripotent stem Cell (iPSC)-Based neurodegenerative disease models for phenotype recapitulation and drug screening. Molecules 25, 2000 (2020).
Marton, R. M. & Pas¸ca, S. P. Neural differentiation in the third dimension: generating a human midbrain. Cell Stem Cell 19, 145–146 (2016).
Wu, Y.-Y., Chiu, F.-L., Yeh, C.-S. & Kuo, H.-C. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease. Open. Biol. 9, 180177 (2019).
Groh, M., Lufino, M. M. P., Wade-Martins, R. & Gromak, N. R-loops associated with triplet repeat expansions promote gene silencing in Friedreich ataxia and fragile X syndrome. PLoS Genet. 10, e1004318 (2014).
Neil, A. J., Liang, M. U., Khristich, A. N., Shah, K. A. & Mirkin, S. M. RNA–DNA hybrids promote the expansion of Friedreich’s ataxia (GAA)n repeats via break-induced replication. Nucleic Acids Res. 46, 3487–3497 (2018).
Gerhardt, J. et al. Stalled DNA replication forks at the endogenous GAA repeats drive repeat expansion in Friedreich’s ataxia cells. Cell Rep. 16, 1218–1227 (2016).